Kishanpura (Dosage Forms) - Rest of World

Production Unit

S.No. Product Name Strength Pack Size

Liquid Injectables

1. Busulfan Injection
6 mg/mL
60 mg/10 mL

2. Carboplatin Injection
10 mg/mL 50 mg/5 mL

150 mg/15 mL

450 mg/45 mL

600 mg/60mL

3. Cisplatin Injection
1 mg/mL
10 mg/10 mL

1 mg/mL
50 mg/50 mL

4. Cytarabine Injection
100 mg/mL
100 mg/1 mL

500 mg/5 mL

1g/10 mL

2g/20 mL

5. Docetaxel Injection Concentrate
20 mg/mL
20 mg/1 mL

80 mg/4 mL

120 mg/6 mL

160 mg/8 mL

180 mg/9 mL

6. Doxorubicin Hydrochloride Injection
2 mg/mL
10 mg/5 mL

50 mg/25 mL

7. Epirubicin Hydrochloride Injection
2 mg/mL
10 mg/5 mL

50 mg/25 mL

8. Etoposide Injection
20 mg/mL

100 mg/5 mL

200 mg/10 mL

500 mg/25 mL

1g/50 mL

9. Fluorouracil Injection
50 mg/mL
250 mg/5 mL

500 mg/10 mL

10. Gemcitabine Injection(RTU RTS)
38 mg/mL
200 mg/5.26 mL

1g/26.3 mL

1.4g/36.8 mL

2g/52.6 mL

11. Irinotecan Hydrochloride Injection
20 mg/mL
40 mg/2 mL

100 mg/5 mL

300 mg/15 mL

500 mg/25 mL

12. Methotrexate Injection
25 mg/mL
50 mg/2 mL

500 mg/20 mL

13. Oxaliplatin Injection
5 mg/mL
50 mg/10 mL

100 mg/20 mL

200 mg/40 mL

14. Paclitaxel Injection
6 mg/mL
30mg/5 mL

100mg/16.7 mL

150mg/25 mL

260mg/43.4 mL

300mg/50 mL

S.No.	Product Name	Strength	Pack Size
Liquid Injectables
1.	Busulfan Injection	6 mg/mL	60 mg/10 mL
2.	Carboplatin Injection	10 mg/mL	50 mg/5 mL
150 mg/15 mL
450 mg/45 mL
600 mg/60mL
3.	Cisplatin Injection	1 mg/mL	10 mg/10 mL
1 mg/mL	50 mg/50 mL
4.	Cytarabine Injection	100 mg/mL	100 mg/1 mL
500 mg/5 mL
1g/10 mL
2g/20 mL
5.	Docetaxel Injection Concentrate	20 mg/mL	20 mg/1 mL
80 mg/4 mL
120 mg/6 mL
160 mg/8 mL
180 mg/9 mL
6.	Doxorubicin Hydrochloride Injection	2 mg/mL	10 mg/5 mL
50 mg/25 mL
7.	Epirubicin Hydrochloride Injection	2 mg/mL	10 mg/5 mL
50 mg/25 mL
8.	Etoposide Injection	20 mg/mL
100 mg/5 mL
200 mg/10 mL
500 mg/25 mL
1g/50 mL
9.	Fluorouracil Injection	50 mg/mL	250 mg/5 mL
500 mg/10 mL
10.	Gemcitabine Injection(RTU RTS)	38 mg/mL	200 mg/5.26 mL
1g/26.3 mL
1.4g/36.8 mL
2g/52.6 mL
11.	Irinotecan Hydrochloride Injection	20 mg/mL	40 mg/2 mL
100 mg/5 mL
300 mg/15 mL
500 mg/25 mL
12.	Methotrexate Injection	25 mg/mL	50 mg/2 mL
500 mg/20 mL
13.	Oxaliplatin Injection	5 mg/mL	50 mg/10 mL
100 mg/20 mL
200 mg/40 mL
14.	Paclitaxel Injection	6 mg/mL	30mg/5 mL
100mg/16.7 mL
150mg/25 mL
260mg/43.4 mL
300mg/50 mL

15.	Paclitaxel solution for Nanoparticles Injection	20 mg/mL	30 mg/1.5 mL
			100 mg/5 mL
			300 mg/15 mL
15.1.	Concentrate of Excipients for Paclitaxel solution for Nanoparticles Injection	10 mg/mL of Polymer	1.5 mL
			5 mL
			15 mL
16.	Topotecan Injection	1 mg/mL	1 mg/1 mL
			2.5 mg/2.5 mL
			4 g/4 mL
17.	Vinorelbine Injection	10 mg/mL	10 mg/1 mL
			50 mg/5 mL
18.	Cladribine Injection	1 mg/mL	10 mg/10 mL
19.	Pemetrexed Injection	25 mg/ml	100 mg/4 mL
			500 mg/20 mL
			1000 mg/40 mL
20.	Bendamustine Hydrochloride for Injection	25 mg/vial	25 mg/vial
		100 mg/vial	100 mg/vial
21.	Gemcitabine for Injection	200 mg/vial	200 mg/vial
		1 g/vial	1 g/vial
		1.4 g/vial	1.4 g/vial
		2 g/vial	2 g/vial
22.	Pemetrexed for Injection	100 mg/vial	100 mg/vial
		500 mg/vial	500 mg/vial
23.	Bortezomib For Injection	3.5 mg/vial	3.5 mg/vial
		1.0 mg/vial	1.0 mg/vial
		2.5 mg/vial	2.5 mg/vial

24.	Azacitidine For Injection	100 mg/vial	100 mg/vial
25.	Caspofungin Acetate for Injection	50 mg/vial	10 ml/vial
25.	Caspofungin Acetate for Injection	70 mg/vial	10 ml/vial
26.	Lacosamide Injection	10 mg/vial	200 mg/vial
27.	Vancomycin powder for solution for infusion	1 g/vial	1 g/vial
27.	Vancomycin powder for solution for infusion	500 mg/vial	500 mg/vial
28.	Daptomycin powder for solution for infusion	300 mg/vial	300 mg/vial
28.	Daptomycin powder for solution for infusion	500 mg/vial	500 mg/vial
29.	Parecoxib powder for solution for infusion	40 mg/vial	40 mg/vial
30.	Temozolomide Capsules	5 mg	5’s,14’s,20’s
		20 mg
		100 mg
		140 mg
		180 mg
		250 mg

Fresenius Kabi Oncology Ltd. do not intend to manufacture any product commercially until there is a valid IP. Listing of product shall not be construed in any way that Fresenius Kabi Oncology has violated any IP laws of the land.